Global Health

Antimicrobial Resistance in Nigeria: Why the Pharmacist Is the Frontline Nobody Funded

Prof. Cecilia Igwilo, OON, FNAPharm
September 25, 2026
7 min read
Antimicrobial Resistance in Nigeria: Why the Pharmacist Is the Frontline Nobody Funded

Antimicrobial resistance is usually described as a future catastrophe. In Nigeria it is a present one — measured not in newsreels but in treatment failures on ordinary wards, in newborn sepsis that no longer yields to first-line therapy, in typhoid cases that shrug at the drugs that worked a decade ago. And of all the professions that touch this problem, one sits at its physical choke point, at the counter, at the moment of every transaction: pharmacy.

This is the frontline view — and the practice playbook.

Why the Pharmacist Is the Choke Point

Every antimicrobial that a Nigerian patient consumes passed through (or, worryingly, around) a pharmacy. The pharmacist's counter is where three AMR engines are either switched on or switched off:

  1. Dispensing on demand. Antibiotics supplied without prescriptions — over the counter, on request, on familiarity — is the single most direct fuel for self-medication resistance. Every time a pharmacist refuses an unjustified antibiotic request and offers a real alternative, the selection pressure drops.
  2. Course completion. The patient who stops at day three because "I feel better" has just conducted a resistance-selection experiment on themselves. The counselling minute that prevents it is the cheapest AMR intervention in existence.
  3. Product quality. Substandard and falsified antimicrobials — under-dosed, degraded, or fake — deliver half-therapy that breeds tolerance. The pharmacist who sources only quality-assured stock is doing surveillance work that no laboratory report will ever credit.

The Community Playbook

  • Make the prescription rule non-negotiable — and make the alternative real. The pharmacist who refuses the antibiotic but sends the patient to care (or documents and refers) converts refusal into access.
  • Counsel in the patient's language, concretely. "Finish all of them, even when you feel fine. Same time each day. Don't give any to your brother." Hand the patient the reason, not just the instruction.
  • Own the disposal point. Leftover antibiotics should come back to you. Take them, destroy them properly, and tell the story publicly — it teaches the culture.
  • Watch for failure patterns. A neighbourhood where the same antibiotic keeps failing is an AMR signal. Log it, discuss it with prescribers, report through pharmacovigilance channels.
  • Lead the vaccination conversation. Every prevented infection is an antibiotic never needed. Pharmacists are the most accessible immunisation educators the system has.

The Hospital Playbook

Hospital pharmacy's AMR weapon is stewardship — and its authority has just been upgraded. The consultant pharmacist cadre puts pharmacists at specialist rank inside institutions, precisely where stewardship committees need them:

  • Order review with teeth — intervening on inappropriate empiric choices, duplications, and durations, with escalation rights the cadre formalises.
  • Consumption surveillance — units-of-use data by ward, reviewed monthly, shared with prescribers without blame but with persistence.
  • De-escalation culture — the institutional habit of starting broad where justified and narrowing when culture results arrive. Pharmacists are the memory that makes this happen.
  • Education that lands — quarterly feedback to departments beats annual lectures; pharmacists run the feedback.

The System Gaps — Stated Honestly

Nigeria's AMR response faces constraints pharmacists cannot fix alone: diagnostics scarcity (empiric therapy is often rational given no cultures), surveillance coverage that is improving but incomplete, and informal drug markets that operate entirely outside professional channels. The Academy's policy position, consistent with its public stances on regulatory strengthening, is that supply-side enforcement and pharmacist-anchored stewardship are the highest-yield investments available.

But the gap that pharmacists control — the one at the counter — is controlled by pharmacists individually, today, without waiting for anyone.

One Counter, One Transaction at a Time

World Pharmacists Day 2026 is a fitting moment to say the quiet part: the profession's most consequential global-health contribution may not come from any single programme, but from a million counters doing the boring thing right — the prescription checked, the course explained, the substandard stock refused.

If you run a practice and want the patient-facing materials, our AMR infographic pack is free to print and share. To follow the policy and surveillance developments as they land, subscribe to NAPharm Insights.

Frequently Asked Questions

Tags

AMR
Public Health
Stewardship
Community Pharmacy

Share this article

Related Articles